Condition 1: Chronic kidney disease. Condition 2: Coagulapathy. Chronic kidney disease (CKD) Coagulation defect, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Intraoperative fluid therapy in the this group would be albumin 5% equal to bleeding volume. To study patients' coagulation status, Prothrombin time (PT), Partial t
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Men and women 18 to 75 years The risk of anesthesia is 1 or 2 with the division of the American Anesthesia Association A blood urea of less than 38.5 mg / dl Have a blood creatinine of less than 1.3 mg / dL Blood platelets range between 150,000 and 300,000 Patient INR less than 1.2 The patient's consent form must be signed by the patient
Exclusion criteria
Exclusion criteria: Patient with a history of liver disease Patient with a history of heart failure Patient history of kidney disease Patient with a history of coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of albumin on renal system activity. Timepoint: Preoperatively and 6, 12 and 24 hours postoperatively. Method of measurement: Calometric. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of albumin on coagulation activity. Timepoint: Preoperatively and 6,12,24 hours postoperatively. Method of measurement: Coagulometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Madineh
Shahre-kord University of Medical Sciences
Outcome results
None listed